NXTC

NextCure, Inc.$6.35-0.29 (-4.37%)

Prev Close$6.64·MCap$24.7M·P/E—·Vol155.3K·Yield—

▲

Buys (12M)

$1.61M

▼

Sells (12M)

$184.8K

◆

Net Activity

Net Buyer

$1.43M

●

Active Insiders

last 12 mo

Over the past 12 months, insider activity at NextCure, Inc. (NXTC) has been dominated by buying, with 2 insider purchases totaling $1.61M and 1 insider sale totaling $184.8K. The most recent insider transaction was by Simcere Zaiming, Inc. (other: Former 10% Owner), who sold $184.8K worth of shares on Aug 12, 2026. NextCure, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $24.7M.

NXTC Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Aug 12, 2026	Simcere Zaiming, Inc.	other: Former 10% Owner	Sell	30,000	$6.16	$184.8K0.8% OS	308,636
Aug 3, 2026	ADAR1 Capital Management, LLC	10 percent owner	Buy	309,153	$4.93	$1.52M8.6% OS	722,419+75%
Jul 29, 2026	ADAR1 Capital Management, LLC	10 percent owner	Buy	17,608	$4.98	$87.7K	393,266

NXTC Insider Buying Activity

The following table shows recent insider purchases of NextCure, Inc. (NXTC) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Aug 3, 2026	ADAR1 Capital Management, LLC	10 percent owner	Buy	309,153	$4.93	$1.52M8.6% OS	722,419+75%
Jul 29, 2026	ADAR1 Capital Management, LLC	10 percent owner	Buy	17,608	$4.98	$87.7K	393,266